The FDA announced on 2023-10-30 that Abbott Molecular, Inc. is recalling Alinity m HCV AMP kits due to risks of false positive results in patient samples. The agency issued recall number Z-0407-2024 for the Class II voluntary recall.
How to tell if you have it
- Brand: Abbott
- Product: Alinity m HCV AMP kit
- REF Numbers: 08N50-095, 08N50-090
- Lot Numbers (REF 08N50-095): 381582, 382448, 383204
- Lot Numbers (REF 08N50-090): 383203, 385720, 381581, 382447
- Units affected: 1,881
The hazard
According to the FDA, Abbott has received reports of an increase in reactive negative controls and false positive results in patient samples when using the identified lots. The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay used to detect and quantitate hepatitis C virus (HCV) RNA.
Context
GovInfoNow's records show Abbott Molecular, Inc. has had 19 other recalls on record since 2021-08-04. Other recent recalls of similar products include Abbott Alinity m Resp-4-Plex AMP Kit Recall (2025-04-28), Abbott Alinity m System Recall (2025-03-20), and Abbott Alinity m STI AMP Kit Recall (2024-09-12). Other recent recalls of similar products include Hologic Aptima HPV Assay Kit Recall (2026-02-18), Abbott ID NOW Influenza A & B 2 Kit (2026-02-09), and Siemens Atellica CH Urine Albumin Recall (2026-07-06).